Clinical Trial Phase IV

Post-marketing surveillance studies conducted after a compound has received regulatory approval. Phase IV trials monitor long-term safety and efficacy in larger, more diverse populations than pre-approval trials. They may also investigate new indications, optimal use in combination with other compounds, or effects in specific subpopulations. Phase IV data can lead to label changes or, in rare cases, market withdrawal.